home / stock / opnt / opnt news

OPNT News and Press, Opiant Pharmaceuticals Inc. From 05/20/22

Stock Information
Company Name: Opiant Pharmaceuticals Inc.
Stock Symbol: OPNT
Market: NASDAQ
Menu
OPNT OPNT Quote OPNT Short OPNT News OPNT Articles OPNT Message Board
Get OPNT Alerts

News, Short Squeeze, Breakout and More Instantly...
OPNT - Opiant Pharmaceuticals to Hold Virtual 2022 Annual Shareholder Meeting on Tuesday, June 14, 2022 at 9:00am PDT

SANTA MONICA, Calif., May 20, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), announced today that to protect the health and safety of its shareholders, employees, and communities amidst a rise locally in COVID-19, Opiant's 2022 Annual Mee...
OPNT - Opiant Pharmaceuticals, Inc. (OPNT) CEO Dr. Roger Crystal on Q1 2022 Results - Earnings Call Transcript

Opiant Pharmaceuticals, Inc. (OPNT) Q1 2022 Results Conference Call May 10, 2022 04:30 PM ET Company Participants Ben Atkins - Vice President, Communications and Investor Relations Dr. Roger Crystal - Chief Executive Officer Dr. Phil Skolnick - Chief Scientific Officer David O'Toole - Chief F...

OPNT - Inotiv, TScan Therapeutics top healthcare gainers; Opiant, Renovacor lead losers' pack

Gainers: Inotiv (NOTV) +41%. TScan Therapeutics (TCRX) +23%. SomaLogic (SLGC) +19%. Veru (VERU) +18%. Celularity (CELU) +17%. Losers: Opiant Pharmaceuticals (OPNT) -16%. Renovacor (RCOR) -15%. Embecta (EMBC) -7%. Wave Life Sciences (WVE) -5%. ...

OPNT - CRGE, SKYX and GMGI among mid-day movers

Gainers: Trecora Resources (TREC) +27%. Golden Matrix Group (GMGI) +24%. Charge Enterprises (CRGE) +21%. Inspired Entertainment (INSE) +20%. Celsius Holdings (CELH) +20%. QualTek Services (QTEK) +18%. Blue Water Vaccines (BWV) +18%. Grocery Outlet Holding (GO) +17%. H&R Block (HRB) +17%. ...
OPNT - Opiant Pharmaceuticals GAAP EPS of -$2.43 misses by $1.68, revenue of $4.47M misses by $1.43M

Opiant Pharmaceuticals press release (NASDAQ:OPNT): Q1 GAAP EPS of -$2.43 misses by $1.68. Revenue of $4.47M (-30.0% Y/Y) misses by $1.43M. For further details see: Opiant Pharmaceuticals GAAP EPS of -$2.43 misses by $1.68, revenue of $4.47M misses by $1.43M

OPNT - Opiant Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update

SANTA MONICA, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today reported financial results for the three months ended March ...

OPNT - Opiant Pharmaceuticals to Report First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 10, 2022

SANTA MONICA, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, will report its financial results for the first quarter ended Marc...
OPNT - ANIX and CPS among mid-day movers

Gainers: GTY Technology Holdings (GTYH) +114%. Vaxxinity (VAXX) +57%. Zymeworks (ZYME) +35%. Redbox Entertainment (RDBX) +33%. Finch Therapeutics Group (FNCH) +29%. Opiant Pharmaceuticals (OPNT) +29%. Puyi (PUYI) +27%. Cyngn (CYN) +24%. Clearwater (CLW) +24%. Anixa Biosciences (ANIX) +21%. Lo...

OPNT - Opiant Pharmaceuticals Issues Statement in Response to Fake Press Release

Opiant Pharmaceuticals Issues Statement in Response to Fake Press Release PR Newswire SANTA MONICA, Calif. , April 29, 2022 /PRNewswire/ -- Opiant Pharmaceuticals (NASDAQ: OPNT) was the subject of a fake news release issued on Friday, April 29, 202...

OPNT - Opiant denies licensing deal for opioid overdose therapy

Update: Opiant Pharmaceuticals (NASDAQ:OPNT) has advised readers to disregard the news release issued via PR Newswire on Thursday about the purported licensing deal to market the company’s opioid overdose therapy OPNT003 in the EU and U.K. “This release contains incorrect inform...
Previous 10 Next 10